Answer
Women of childbearing potential must use effective contraception throughout treatment with Opzelura (ruxolitinib) cream and for 4 weeks after stopping treatment.
Sources for this answer
- Opzelura 15 mg/g creamIncyte Biosciences UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked